Reporting and consideration of health equity factors in randomized controlled trials of mobile-delivered self-management interventions for type 2 diabetes: a scoping review protocol

This scoping review will discribe how equity-relevant factors (e.g., PROGRESS-Plus and context-specific digital access factors) are reported, considered, and analysed across trials of mobile-delivered self-management interventions for T2DM. Rather than estimating an average intervention effect, we aim to summarise reporting practices and identify gaps that need further study, consistent with scoping review methodology.